A detailed history of Degroof Petercam Asset Management transactions in Moderna, Inc. stock. As of the latest transaction made, Degroof Petercam Asset Management holds 7,147 shares of MRNA stock, worth $469,915. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,147
Previous 7,147 -0.0%
Holding current value
$469,915
Previous $711 Million 7.15%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $496,787 - $746,361
7,147 New
7,147 $711 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Degroof Petercam Asset Management Portfolio

Follow Degroof Petercam Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Degroof Petercam Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Degroof Petercam Asset Management with notifications on news.